Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,062 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

NCT00369681

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

NCT00169143

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Hôpital Henri Mondor Créteil, France
  • Service d'Hématologie Clinique - CHU Le Bocage Dijon, France
  • Hôpital Saint Louis Paris, France
  • Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France
View Trial Details
Completed

Lenalidomide and R-CHOP in B-cell Lymphoma

NCT00901615

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • CHU de Dijon Dijon, France
  • CHRU Lille Lille, France
  • CHU Lyon Sud Pierre-Bénite, France
  • Centre Henri Becquerel Rouen, France
View Trial Details

Related conditions